Pharmaceutical Manufacturer Achieves Faster QC Release with Standardized Microbiological Testing Supplies

Case Study: Pharmaceutical Manufacturer Achieves Faster QC Release

Customer Background

A mid-sized pharmaceutical manufacturer in the Middle East produces oral solid dosage forms and liquid preparations for regional and export markets. Its quality control laboratory performs sterility testing, microbial enumeration and water system monitoring in compliance with USP and EP requirements. The company faced growing pressure to shorten batch release cycles while maintaining strict compliance with regulatory standards and expanding its product portfolio.

Challenges

• Manual preparation of culture media consumed significant technician time and introduced variability between batches.
• Existing microbial identification workflow relied on outdated biochemical methods that took up to 5 days to deliver results.
• Supplier inconsistency in raw materials threatened GMP audit readiness and created documentation gaps.
• Increasing production volumes demanded a more scalable and standardized approach to microbiological quality control.

Our Solution

We provided ready-to-use prepared culture media plates, sterile diluents, microbial identification test kits and a reliable supply of laboratory consumables including petri dishes, loops and spreaders. Our technical team supported method verification with reference strains and provided complete documentation packages aligned with GMP documentation requirements, including certificates of analysis and sterility test reports for every delivered lot.

Implementation

We began with a gap analysis of the laboratory's existing media preparation and identification workflows. After a successful qualification phase, we transitioned the laboratory to ready-to-use media with a validated cold-chain delivery schedule. Technicians were trained on aseptic handling, incubation parameters and rapid identification interpretation, ensuring a smooth migration with zero disruption to ongoing production testing.

Results

Customer Feedback

"Switching to standardized ready-to-use media has transformed our QC workflow. Our team now focuses on analysis instead of preparation, and the consistent documentation has made our GMP audits significantly smoother. The reduction in release time has directly improved our cash flow and customer delivery performance."

Conclusion

In addition, the laboratory now benefits from a dedicated account manager who coordinates forecasting, quality reviews and annual audits, ensuring continuous alignment with evolving regulatory expectations. The manufacturer has since expanded the cooperation to its new injectable production line, relying on our microbiology supplies for sterility testing and environmental monitoring programs. This partnership highlights how standardized, high-quality microbiological testing supplies can accelerate pharmaceutical quality control while strengthening regulatory compliance and operational efficiency.